Kurt Grünewald

2.8k total citations · 1 hit paper
29 papers, 2.2k citations indexed

About

Kurt Grünewald is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Kurt Grünewald has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 7 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Kurt Grünewald's work include Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Acute Myeloid Leukemia Research (4 papers). Kurt Grünewald is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Multiple Myeloma Research and Treatments (4 papers) and Acute Myeloid Leukemia Research (4 papers). Kurt Grünewald collaborates with scholars based in Austria, Germany and United States. Kurt Grünewald's co-authors include John F. Lyons, Hans G. Feichtinger, Ernest S. Kawasaki, Griffith Harsh, Frank McCormick, Claudia A. Landis, Henry R. Bourne, Quan‐Yang Duh, Orlo H. Clark and Lucia Vallar and has published in prestigious journals such as Science, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Kurt Grünewald

29 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Two G Protein Oncogenes in Human Endocrine Tumors

1990 827 citations John F. Lyons, Kurt Grünewald et al. profile →

Peers

Countries citing papers authored by Kurt Grünewald

Since Specialization

Citations

This map shows the geographic impact of Kurt Grünewald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Grünewald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Grünewald more than expected).

Fields of papers citing papers by Kurt Grünewald

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Grünewald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Grünewald. The network helps show where Kurt Grünewald may publish in the future.

Co-authorship network of co-authors of Kurt Grünewald

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Grünewald. A scholar is included among the top collaborators of Kurt Grünewald based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Grünewald. Kurt Grünewald is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue 2006 ·Cancer Letters ·Gilbert Spizzo, Guenther Gastl, Peter Obrist, Dominic Fong, Margot Haun, Kurt Grünewald, Walther Parson, Cordula Eichmann, Simone Millinger, Heidi Fiegl, Raimund Margreiter, Albert Amberger	31
2	High-Dose Hydroxyurea Plus G-CSF Mobilize BCR-ABL-Negative Progenitor Cells (CFC, LTC-IC) into the Blood of Newly Diagnosed CML Patients at Any Time of Hematopoietic Regeneration 2002 ·Journal of Hematotherapy & Stem Cell Research ·Andreas Petzer, (unknown), Margot Haun, (unknown), Kurt Grünewald, (unknown), Heinz Sill, Werner Linkesch, Günther Gastl, Eberhard Gunsilius	6
3	Mammaglobin Expression in Gynecologic Malignancies and Malignant Effusions Detected by Nested Reverse Transcriptase-Polymerase Chain Reaction 2002 ·Laboratory Investigation ·Kurt Grünewald, Margot Haun, Michael Fiegl, Martina Urbanek, Elisabeth Müller‐Holzner, (unknown), (unknown), A Propst, Christian Marth, Günther Gastl	36
4	Low concentrations of STI571 in the cerebrospinal fluid: a case report 2002 ·British Journal of Haematology ·Andreas Petzer, Eberhard Gunsilius, Michael Hayes, Guenther Stockhammer, (unknown), Folker Schneller, Kurt Grünewald, Werner Poewe, Guenther Gastl	76
5	Induction of HA‐1‐specific cytotoxic T‐cell clones parallels the therapeutic effect of donor lymphocyte infusion 2002 ·British Journal of Haematology ·Brigitte Kircher, Stefan Stevanović, Martina Urbanek, (unknown), Hans‐Georg Rammensee, Kurt Grünewald, Günther Gastl, David Nachbaur	50
6	Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells 2000 ·The Lancet ·Eberhard Gunsilius, (unknown), Andreas Petzer, Christian M. Kähler, Kurt Grünewald, Günther Stockhammer, (unknown), Stephan Dirnhofer, Johannes D. Clausen, Günther Gastl	245
7	Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19 2000 ·Laboratory Investigation ·Kurt Grünewald, Margot Haun, Martina Urbanek, Michael Fiegl, Elisabeth Müller‐Holzner, Eberhard Gunsilius, Martina Dünser, Christian Marth, (unknown)	96
8	Expression of Apo‐1/Fas (CD95), Bcl‐2, Bax and Bcl‐x in myeloma cell lines: relationship between responsiveness to anti‐Fas mab and p53 functional status 1997 ·British Journal of Haematology ·Alexander Egle, Andreas Villunger, I Marschitz, Marion Kos, A Hittmair, Peter Lukáš, Kurt Grünewald, Richard Greil	35
9	Modulation of transferrin receptor expression by dexrazoxane (ICRF-187) via activation of iron regulatory protein 1997 ·Biochemical Pharmacology ·Günter Weiß, Stefan Kastner, Jeremy H. Brock, Josef Thaler, Kurt Grünewald	13
10	Differentiation of Primary and Secondary Cutaneous B-Cell Lymphoma by Southern Blot Analysis 1996 ·American Journal of Clinical Pathology ·Norbert Sepp, Katharina Weyrer, Margot Haun, Bernhard Zelger, Josef Thaler, (unknown), Peter Fritsch, Kurt Grünewald	11
11	Quantitation and genotyping of hepatitis C virus RNA in sera of hemodialysis and AIDS patients 1996 ·Clinical and Diagnostic Virology ·Harald H. Kessler, Brigitte I. Santner, Florian Umlauft, (unknown), D Stünzner, Karen Pierer, Evelyn Stelzl, Kurt Grünewald, Egon Marth	4
12	High-dose interferon-α2b treatment prevents chronicity in acute hepatitis C 1996 ·Digestive Diseases and Sciences ·Wolfgang Vogel, Ivo Graziadei, Florian Umlauft, Christian Datz, Franz Hackl, (unknown), Kurt Grünewald, Josef R. Patsch	68
13	Detection of hepatitis C viral sequences in serum by ‘nested’ polymerase chain reaction (PCR) and a commercial single-round PCR assay 1995 ·Clinical and Diagnostic Virology ·Harald H. Kessler, Brigitte I. Santner, Florian Umlauft, Martina Urbanek, (unknown), Karen Pierer, D Stünzner, Kurt Grünewald, Egon Marth	4
14	Stimulation of IRE-BP Activity of IRF by Tetrahydrobiopterin and Cytokine Dependent Induction of Nitric Oxide Synthase 1994 ·Advances in experimental medicine and biology ·Günter Weiß, Kurt Grünewald, Kostas Pantopoulos, B. Goossen, Matthias W. Hentze, Wolfgang Doppler, Dietmar Fuchs, Gabriele Werner‐Felmayer, (unknown)	5
15	Immunoglobulin Gene Rearrangement in Plasma Cell Dyscrasias: Detection of Small Clonal Cell Populations in Peripheral Blood and Bone Marrow 1993 ·Leukemia & lymphoma ·Falko Fend, Katharina Weyrer, Johannes Drach, (unknown), (unknown), Kurt Grünewald	12
16	Long‐term follow‐up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration 1993 ·British Journal of Haematology ·J. Thaler, Kurt Grünewald, (unknown), Anthony D. Ho, Katharina Weyrer, Otto Dietze, Reinhard Stauder, (unknown), Alois Lang, H. Huber	25
17	Gene Rearrangement Studies in the Diagnosis of Primary Systemic and Nodular Primary Localized Cutaneous Amyloidosis 1991 ·Journal of Investigative Dermatology ·Kurt Grünewald, Norbert Sepp, Katharina Weyrer, Karl Lhotta, Hans G. Feichtinger, Günther Konwalinka, Stephen M. Breathnach, Helmut Hintner	40
18	Urinary Neopterin as a Prognostic Factor in Haematological Neoplasias 1989 ·Pteridines ·H. Denz, Kurt Grünewald, Josef Thaler, H. Huber, Dietmar Fuchs, Arno Hausen, Gilbert Reibnegger, Ernst R. Werner, Helmut Wächter	15
19	High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas 1989 ·International Journal of Cancer ·Kurt Grünewald, John F. Lyons, Anja Fröhlich, Hans G. Feichtinger, (unknown), G. Schwab, Johannes W.G. Janssen, Claus R. Bartram	244
20	Stimulation of Human Early and Late Erythropoietic Progenitor Cells by Insulin: Evidence for Different Mechanisms 1988 ·Advances in experimental medicine and biology ·Günther Konwalinka, Christian J. Wiedermann, Andreas Petzer, Kurt Grünewald, (unknown), Josef R. Patsch, D. Geißler	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact